Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | GM-CSF | 196.0 | 63 | |
| RA2159 | Leptin | 1 | ng/mL | 3 | GM-CSF | 210.0 | 61 | ||||
| RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | GM-CSF | 199.0 | 50 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | GM-CSF | 169.5 | 50 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | GM-CSF | 205.0 | 69 | |
| RA2159 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | GM-CSF | 193.0 | 78 | |
| RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | GM-CSF | 189.0 | 80 | |
| N2586 | Leptin | 1 | ng/mL | 3 | GM-CSF | 197.5 | 60 | ||||
| N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | GM-CSF | 205.0 | 60 | |
| N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | GM-CSF | 200.0 | 77 | |
| N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | GM-CSF | 174.5 | 50 | |
| N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | GM-CSF | 169.0 | 70 | |
| N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | GM-CSF | 197.0 | 77 | |
| RA2159 | Adiponectin | 5 | ng/mL | 3 | GM-CSF | 89.5 | 68 | ||||
| RA2159 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 3 | GM-CSF | 101.0 | 78 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | GM-CSF | 93.0 | 63 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | GM-CSF | 100.5 | 48 | |
| RA2159 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | GM-CSF | 95.0 | 50 | |
| RA2159 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 3 | GM-CSF | 100.0 | 67 | |
| N2586 | Adiponectin | 5 | ng/mL | 3 | GM-CSF | 103.0 | 65 | ||||
| N2586 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 3 | GM-CSF | 95.0 | 67 | |
| N2586 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | GM-CSF | 88.0 | 61 | |
| N2586 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | GM-CSF | 93.0 | 55 | |
| N2586 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | GM-CSF | 87.0 | 72 | |
| N2586 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 3 | GM-CSF | 96.0 | 61 |